RECURRENT PANCREATIC CARCINOMA
Clinical trials for RECURRENT PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise in tough pancreatic cancer fight
Disease control CompletedThis study tested whether adding the drug veliparib to standard chemotherapy (FOLFIRI) could help people with metastatic pancreatic cancer live longer. About 123 patients whose cancer had returned after initial treatment took part. The goal was to see if the combination worked be…
Matched conditions: RECURRENT PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Promising combo tackles Hard-to-Treat GI cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs—pembrolizumab (an immunotherapy) and XL888 (a targeted therapy)—in 47 people with advanced gastrointestinal cancers that had spread or couldn't be removed. The main goal was to find the safest dose and check for side effect…
Matched conditions: RECURRENT PANCREATIC CARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 08:28 UTC